Abstract
Despite the commercial success of in vitro embryo production (IVP), current conditions available in human medicine and the animal production industry are still below ideal. In fact, the loss of in vitro development of bovine oocytes to the blastocyst stage is near 60 to 70%. In this context, improvements to expand productivity and quality can be research and development (R&D), to increase…